These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 110252)

  • 1. Iron requirement and chelator production of staphylococci, Streptococcus faecalis and enterobacteriaceae.
    Marcelis JH; den Daas-Slagt HJ; Hoogkamp-Korstanje JA
    Antonie Van Leeuwenhoek; 1978; 44(3-4):257-67. PubMed ID: 110252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional interchangeability of enterobacterial and staphylococcal iron chelators.
    Maskell JP
    Antonie Van Leeuwenhoek; 1980; 46(4):343-51. PubMed ID: 7447437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterobacterial chelators of iron: their occurrence, detection, and relation to pathogenicity.
    Miles AA; Khimji PL
    J Med Microbiol; 1975 Nov; 8(4):477-90. PubMed ID: 812996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ethylenediamine di-o-hydroxyphenylacetic acid and transferrin on the growth of some bacterial strains in vitro.
    Salamah AA
    Microbiologica; 1992 Oct; 15(4):361-6. PubMed ID: 1435350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
    Schito AM; Piatti G; Stauder M; Bisio A; Giacomelli E; Romussi G; Pruzzo C
    Int J Antimicrob Agents; 2011 Feb; 37(2):129-34. PubMed ID: 21163629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002].
    Eta S; Kawahara M
    Jpn J Antibiot; 2006 Feb; 59(1):21-8. PubMed ID: 16673579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility to desferrioxamines and other chelators of coagulase-negative staphylococci.
    Heuck D; Witte W; Braulke C; Reissbrodt R
    Zentralbl Bakteriol; 1994 Jan; 280(3):304-11. PubMed ID: 8167423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococci express a receptor for human transferrin: identification of a 42-kilodalton cell wall transferrin-binding protein.
    Modun B; Kendall D; Williams P
    Infect Immun; 1994 Sep; 62(9):3850-8. PubMed ID: 8063401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on siderophore exchange properties between staphylococci and various species of gram-positive and gram-negative bacteria].
    Szarapińska-Kwaszewska J; Mikucki J
    Med Dosw Mikrobiol; 1999; 51(3-4):221-32. PubMed ID: 10803251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
    Reynolds R; Potz N; Colman M; Williams A; Livermore D; MacGowan A;
    J Antimicrob Chemother; 2004 Jun; 53(6):1018-32. PubMed ID: 15128723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New fluorescent rosamine chelator showing promising antibacterial activity against Gram-positive bacteria.
    Novais Â; Moniz T; Rebelo AR; Silva AMG; Rangel M; Peixe L
    Bioorg Chem; 2018 Sep; 79():341-349. PubMed ID: 29807207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of pefloxacin compared to other antibiotics.
    Yourassowsky E; Van der Linden MP; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utilization of exogenous siderophores by enterococci].
    Szarapińska-Kwaszewska J; Mikucki J
    Med Dosw Mikrobiol; 2001; 53(3):233-43. PubMed ID: 11785180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.
    van Asbeck BS; Marcelis JH; Marx JJ; Struyvenberg A; van Kats JH; Verhoef J
    Eur J Clin Microbiol; 1983 Oct; 2(5):426-31. PubMed ID: 6416837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of early fecal carriage of Enterococcus faecalis and Staphylococcus spp and their antimicrobial resistant patterns among healthy neonates born in a hospital setting in central Saudi Arabia.
    El-Kersh TA; Marie MA; Al-Sheikh YA; Al-Agamy MH; Al Bloushy AA
    Saudi Med J; 2016 Mar; 37(3):280-7. PubMed ID: 26905350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of American MicroScan dry and frozen microdilution trays.
    Schieven BC; Hussain Z; Lannigan R
    J Clin Microbiol; 1985 Oct; 22(4):495-6. PubMed ID: 3935659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus but not Staphylococcus epidermidis can acquire iron from transferrin.
    Lindsay JA; Riley TV; Mee BJ
    Microbiology (Reading); 1995 Jan; 141 ( Pt 1)():197-203. PubMed ID: 7894712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.